scholarly journals Phase 2 study of nilotinib in pediatric patients with Philadelphia chromosome–positive chronic myeloid leukemia

Blood ◽  
2019 ◽  
Vol 134 (23) ◽  
pp. 2036-2045 ◽  
Author(s):  
Nobuko Hijiya ◽  
Alexey Maschan ◽  
Carmelo Rizzari ◽  
Hiroyuki Shimada ◽  
Carlo Dufour ◽  
...  
Keyword(s):  
Chronic Myeloid Leukemia ◽  
Safety Profile ◽  
Myeloid Leukemia ◽  
Pediatric Patients ◽  
Philadelphia Chromosome ◽  
Phase 2 ◽  
Newly Diagnosed ◽  
Phase 2 Study ◽  
Key Points ◽  
Philadelphia Chromosome Positive

Key Points Nilotinib demonstrated efficacy and a manageable safety profile in pediatric patients with newly diagnosed and pretreated Ph+ CML-CP.

scholarly journals Phase 2 study of bosutinib in Japanese patients with newly diagnosed chronic phase chronic myeloid leukemia

2020 ◽  
Vol 112 (1) ◽  
pp. 24-32
Author(s):  
Masayuki Hino ◽  
Itaru Matsumura ◽  
Shin Fujisawa ◽  
Kenichi Ishizawa ◽  
Takaaki Ono ◽  
...  
Keyword(s):  
Chronic Myeloid Leukemia ◽  
Myeloid Leukemia ◽  
Chronic Phase ◽  
Japanese Patients ◽  
Phase 2 ◽  
Newly Diagnosed ◽  
Phase 2 Study
Sign in / Sign up

Export Citation Format

Share Document